Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PCAR vs MRNA✓SelectedUSD · MRNAPCAR vs MRNA performance historyLatest closeAs of+0.33%11/19
Stock and ETF performance explorer

PCAR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+26.6%
MRNA return
+159.5%
Excess return
-132.9%
Maximum drawdown
-27.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.3%+1.3%-1.0%+0.3%
7D-2.1%-13.8%+11.8%-1.6%
30D-5.1%-17.7%+12.6%-4.6%
3M-18.0%+14.3%-32.3%-18.6%
6M-4.2%+336.0%-340.2%-14.4%
YTD-3.8%+575.9%-579.7%-19.4%
1Y+10.6%+724.4%-713.8%-9.8%
All+26.6%+159.5%-132.9%+12.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling